Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

this-rocket-lab-analyst-begins-coverage-on-a-bullish-note;-here-are-top-5-initiations-for-thursday-–-apogee-therapeutics-(nasdaq:apge),-arcturus-therapeutics-(nasdaq:arct)

This Rocket Lab Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday – Apogee Therapeutics (NASDAQ:APGE), Arcturus Therapeutics (NASDAQ:ARCT)

Mar 19, 2026

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…

Read more
goldman-sachs-maintains-neutral-on-wbi-(waterbridge-infrastructure-llc)-march-2026

Goldman Sachs Maintains Neutral on WBI (WaterBridge Infrastructure LLC) March 2026

Mar 19, 2026

Goldman Sachs on March 17, 2026 maintained a Neutral rating on WaterBridge Infrastructure LLC (WBI) while raising its…

Read more
ubs-maintains-buy-on-eli-lilly-and-company-(lly)-march-18,-2026

UBS Maintains Buy on Eli Lilly and Company (LLY) March 18, 2026

Mar 19, 2026

Get analyst ratings, AI forecasts, and market updates in your inbox every morning. ~15% average open rate and…

Read more
bmo-maintains-market-perform-on-healthequity-(hqy)-march-18,-2026

BMO Maintains Market Perform on HealthEquity (HQY) March 18, 2026

Mar 19, 2026

BMO Capital maintained a Market Perform rating on HealthEquity, Inc. (HQY) on March 18, 2026, a clear signal…

Read more
craig-hallum-maintains-buy-on-comscore,-inc.-(scor)-march-18,-2026

Craig-Hallum Maintains Buy on comScore, Inc. (SCOR) March 18, 2026

Mar 19, 2026

Craig-Hallum maintained its Buy rating on comScore, Inc. (SCOR) on March 18, 2026, marking a positive SCOR analyst…

Read more
cowen-maintains-buy-on-sap-(sap-se)-march-18,-2026

Cowen Maintains Buy on SAP (SAP SE) March 18, 2026

Mar 19, 2026

Cowen & Co. maintained a Buy on SAP (SAP SE) on March 18, 2026, the most notable recent…

Read more
maintained-buy-for-ts-tenaris-sa.-by-cowen-on-mar-18,-2026

Maintained Buy for TS Tenaris S.A. by Cowen on Mar 18, 2026

Mar 19, 2026

Cowen maintained a Buy on Tenaris S.A. (TS) and raised the price target to $60 on March 18,…

Read more
jefferies-maintains-buy-on-ctmx-(cytomx-therapeutics)-march-18,-2026

Jefferies Maintains Buy on CTMX (CytomX Therapeutics) March 18, 2026

Mar 19, 2026

Jefferies maintained a Buy on CTMX (CytomX Therapeutics, Inc.) on March 18, 2026, raising its price target to…

Read more
leerink-maintains-outperform-on-btsg-brightspring-health-services-mar-18-2026

Leerink Maintains Outperform on BTSG BrightSpring Health Services Mar 18 2026

Mar 19, 2026

Leerink Partners maintained an Outperform on BrightSpring Health Services, Inc. Common Stock (BTSG) on March 18, 2026. The…

Read more
jefferies-maintains-buy-on-interdigital,-inc.-(idcc)-march-18,-2026

Jefferies Maintains Buy on InterDigital, Inc. (IDCC) March 18, 2026

Mar 19, 2026

On March 18, 2026 Jefferies maintained a Buy on InterDigital, Inc. (IDCC), a clear signal in the latest…

Read more
macquarie-maintains-outperform-on-gds-holdings-limited-(gds)-mar-18-2026

Macquarie Maintains Outperform on GDS Holdings Limited (GDS) Mar 18 2026

Mar 19, 2026

Macquarie on March 18, 2026 maintained an Outperform rating on GDS Holdings Limited (GDS) and raised its price…

Read more
jefferies-maintains-buy-on-macy’s-(m)-march-18,-2026

Jefferies Maintains Buy on Macy’s (M) March 18, 2026

Mar 18, 2026

Jefferies reiterated a Buy rating on Macy’s (M) on March 18, 2026, citing an encouraging Q1 comparable-sales guide.…

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 120
  6. 121
  7. 122
  8. 123
  9. 124
  10. 125
  11. 126
  12. ...
  13. 497
  14. »

Posts pagination

Newer posts Page 1 … Page 123 … Page 497 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.